BioMarin
BioMarin R&D chief reveals two new pipeline candidates and strategy to sustain innovation
Anika Sharma
BioMarin, the California-based biotech giant, is embarking on a mission to create its most robust pipeline in history, with a ...
Voxzogo Demand Outstrips Supply: BioMarin’s Growth Dilemma
SG Tylor
BioMarin is facing challenges due to the overwhelming success of its drug, Voxzogo, used to treat achondroplasia, a type of ...
BioMarin’s Roctavian: FDA Approves Hemophilia A Gene Therapy with Positive Reception from Physician
SG Tylor
Source – BioMarin BioMarin’s Roctavian, a gene therapy for severe hemophilia A, has received FDA approval after initial rejection in ...
Analysts predict that BioMarin’s hemophilia A gene therapy may succeed in Europe
SG Tylor
According to a report published by SVB Securities analysts Joseph Schwartz and Joori Park, Ph.D., Roctavian may have a “significant ...
